A novel drug developed in St. Louis for the treatment of rheumatoid arthritis is being investigated as a possible treatment for COVID-19. The anti-inflammatory drug, ATI-450, is informally named after drug maker Aclaris Therapeutics, Inc. with an assigned number. The…